Synthorx
Latest round
- Series C
Last raised
- Apr 2018
Total raised
- $73M
Investors
- 6
About Synthorx
Synthorx, Inc. is a biotechnology company focused on developing innovative therapies through the creation of a unique amino acid.Founded in 2014 and headquartered in the United States, Synthorx, Inc. specializes in therapeutic solutions utilizing a proprietary amino acid technology.Synthorx, Inc. offers innovative biopharmaceutical therapies designed to improve treatment outcomes in various diseases. Their products leverage a distinct amino acid that allows for enhanced therapeutic effects, aiming to address unmet medical needs.For the most recent year, Synthorx, Inc.65 mn, indicating operational losses.Looking ahead, Synthorx plans to launch new therapies that capitalize on their unique amino acid technology, with specific release dates to be announced as development progresses. The company aims to expand its reach into European and Asian markets further by 2021.
Who invested in Synthorx
6 investors across 3 rounds
See all investors in Synthorx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synthorx
Who invested in Synthorx?
Synthorx has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synthorx raised?
Synthorx has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Synthorx last raise money?
Synthorx's most recent round on record is a Series C, in Apr 2018.
What does Synthorx do?
Synthorx is a biotechnology company.
Where is Synthorx headquartered?
Synthorx is headquartered in US.
Which VCs invest in companies like Synthorx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Synthorx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Synthorx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.